Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing cimetidine and sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
2 |
Product containing sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
1 |
Product containing magnesium alginate and sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
2 |
Product containing potassium bicarbonate and sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
1 |
Sodium alginate 500mg/5ml / Potassium bicarbonate 100mg/5ml oral suspension sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium alginate |
Inferred relationship |
Some |
|
Sodium alginate 225mg/dose / Magnesium alginate 87.5mg/dose oral powder sachet sugar free |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sodium alginate |
Inferred relationship |
Some |
|
Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium alginate |
Inferred relationship |
Some |
2 |
Magnesium alginate 87.5 mg and sodium alginate 225 mg powder for oral suspension sachet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium alginate |
Inferred relationship |
Some |
2 |
Product containing precisely potassium bicarbonate 20 milligram/1 milliliter and sodium alginate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Sodium alginate |
Inferred relationship |
Some |
2 |
Product containing precisely potassium bicarbonate 20 milligram/1 milliliter and sodium alginate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Sodium alginate |
Inferred relationship |
Some |
2 |
Potassium bicarbonate- and sodium alginate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
1 |
Product containing magnesium alginate and sodium alginate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
2 |
Product containing only cimetidine and sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
2 |
Magnesium alginate and sodium alginate only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
2 |
Product containing only sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
1 |
Product containing only potassium bicarbonate and sodium alginate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
1 |
Product containing only potassium bicarbonate and sodium alginate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
1 |
Product containing only magnesium alginate and sodium alginate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
2 |
Product containing precisely potassium bicarbonate 20 milligram/1 milliliter and sodium alginate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium alginate |
Inferred relationship |
Some |
1 |
Product containing precisely potassium bicarbonate 20 milligram/1 milliliter and sodium alginate 100 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium alginate |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 32.5 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 21.3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium alginate |
Inferred relationship |
Some |
3 |
Product containing precisely calcium carbonate 32.5 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 21.3 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium alginate |
Inferred relationship |
Some |
3 |
Calcium carbonate and sodium alginate and sodium bicarbonate only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
3 |
Sodium alginate-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
1 |
Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Sodium alginate |
Inferred relationship |
Some |
3 |
Product containing precisely calcium carbonate 16 milligram/1 milliliter and sodium alginate 50 milligram/1 milliliter and sodium bicarbonate 26.7 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Sodium alginate |
Inferred relationship |
Some |
3 |
Product containing calcium carbonate and sodium alginate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
3 |
Product containing only calcium carbonate and sodium alginate and sodium bicarbonate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
3 |
Product containing calcium carbonate and sodium alginate and sodium bicarbonate in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sodium alginate |
Inferred relationship |
Some |
3 |